Pacira Pharm Inc (PCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2020 | 12-2019 | 09-2019 | 06-2019 | 03-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 54,589 | 78,228 | 85,139 | 59,737 | 215,036 |
| Marketable Securities | 263,875 | 213,722 | 180,505 | 232,502 | 197,406 |
| Receivables | 38,988 | 47,530 | 42,573 | 41,147 | 39,766 |
| Inventories | 59,666 | 58,296 | 60,238 | 52,697 | 47,028 |
| TOTAL | $431,594 | $408,557 | $378,847 | $394,609 | $508,673 |
| Non-Current Assets | |||||
| PPE Net | 108,105 | 104,681 | 104,856 | 105,492 | 107,051 |
| Investments And Advances | 42,099 | 75,769 | 82,129 | 42,390 | 14,146 |
| Intangibles | 201,968 | 203,934 | 205,901 | 208,858 | 62,040 |
| Other Non-Current Assets | 37,613 | 38,124 | 35,756 | 36,494 | 27,246 |
| TOTAL | $389,785 | $422,508 | $428,642 | $393,234 | $210,483 |
| Total Assets | $821,379 | $831,065 | $807,489 | $787,843 | $719,156 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 15,850 | 12,799 | 16,064 | 13,347 | 13,369 |
| Accrued Expenses | 44,717 | 70,427 | 61,002 | 51,907 | 39,696 |
| Other current liabilities | 14,041 | 18,179 | 13,591 | 11,500 | N/A |
| TOTAL | $80,313 | $107,673 | $95,838 | $83,004 | $58,991 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 367,029 | 368,448 | 365,489 | 363,189 | 332,646 |
| TOTAL | $367,029 | $368,448 | $365,489 | $363,189 | $332,646 |
| Total Liabilities | $447,342 | $476,121 | $461,327 | $446,193 | $391,637 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 42,121 | 42,033 | 41,731 | 41,635 | 41,297 |
| Common Shares | 42 | 42 | 42 | 42 | 41 |
| Retained earnings | -391,239 | -399,398 | -394,510 | -388,423 | -391,153 |
| Other shareholders' equity | -1,046 | 322 | 447 | 500 | 182 |
| TOTAL | $374,037 | $354,944 | $346,162 | $341,650 | $327,519 |
| Total Liabilities And Equity | $821,379 | $831,065 | $807,489 | $787,843 | $719,156 |